Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005086 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00005086 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 6 participants.
The verdict
NCT00005086, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have stage IV locally advanced or metastatic bladder cancer.
Interventions
- DRUG cisplatin
- DRUG docetaxel
- DRUG methotrexate
- DRUG gemcitabine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 1999-08 |
| Est. Completion | 2005-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005086
The ClinicalTrials.gov registry entry for NCT00005086 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which cisplatin is the first listed.
NCT00005086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005086 about?
NCT00005086 is a clinical study titled "Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have stage IV local...
What is the current status of trial NCT00005086?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 1999-08. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00005086?
The interventions under investigation include: cisplatin (DRUG), docetaxel (DRUG), methotrexate (DRUG), gemcitabine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00005086?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.